These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators. Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173 [Abstract] [Full Text] [Related]
4. How to use the C-reactive protein in cardiac disease? Ursella S, Mazzone M, Portale G, Testa A, Pignataro G, Covino M, Fenici P, Gasbarrini GB, Gentiloni Silveri N. Minerva Cardioangiol; 2005 Feb 27; 53(1):59-68. PubMed ID: 15788980 [Abstract] [Full Text] [Related]
5. The variable role of inflammation in acute coronary syndromes and in restenosis. Biasucci LM, Liuzzo G, Buffon A, Maseri A. Semin Interv Cardiol; 1999 Sep 27; 4(3):105-10. PubMed ID: 10545616 [Abstract] [Full Text] [Related]
10. C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes. Abbate A, Biondi-Zoccai GG, Brugaletta S, Liuzzo G, Biasucci LM. Semin Vasc Med; 2003 Nov 27; 3(4):375-84. PubMed ID: 15199444 [Abstract] [Full Text] [Related]
14. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F. J Cardiovasc Med (Hagerstown); 2007 Apr 27; 8(4):293-9. PubMed ID: 17413310 [Abstract] [Full Text] [Related]
15. [Diagnostic and prognostic significance of CK-MB, troponins, CRP, BNP and/or NT-proBNP in coronary angioplasty. Elevation mechanisms and clinical implications]. Bertinchant JP, Ledermann B, Schmutz L, Pezzano M, Jamaleddin N, Cade S, Winum PF, Polge A. Arch Mal Coeur Vaiss; 2007 Nov 27; 100(11):925-33. PubMed ID: 18209693 [Abstract] [Full Text] [Related]
16. The new definition of myocardial infarction: analysis of the ESC/ACC Consensus Document and reflections on its applicability to the Italian Health System. Galvani M, Panteghini M, Ottani F, Cappelletti P, Chiarella F, Chiariello M, Crea F, Dolci A, Golino P, Greco C, Nicolosi GL, Plebani M, Tubaro M, Zaninotto M, Intersocietary Study Group "Markers of Myocardial Damage". Ital Heart J; 2002 Sep 27; 3(9):543-57. PubMed ID: 12407856 [Abstract] [Full Text] [Related]
19. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes. Oltrona L, Ottani F, Galvani M, Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Am Heart J; 2004 Sep 27; 148(3):405-15. PubMed ID: 15389226 [Abstract] [Full Text] [Related]